Dmitry Balyasny’s LyondellBasell Industries LYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$653K Sell
12,400
-5,500
-31% -$380K ﹤0.01% 2411
2026
Q1
$1.44M Buy
+17,900
New +$1.06M ﹤0.01% 1928
2025
Q1
Sell
-254,100
Closed -$18.9M 3086
2024
Q4
$18.9M Buy
254,100
+25,200
+11% +$2.12M 0.03% 697
2024
Q3
$22M Hold
228,900
0.04% 593
2024
Q2
$21.9M Sell
228,900
-6,900
-3% -$685K 0.04% 576
2024
Q1
$24.1M Sell
235,800
-73,200
-24% -$7.12M 0.04% 544
2023
Q4
$29.4M Buy
309,000
+9,000
+3% +$842K 0.06% 463
2023
Q3
$28.4M Buy
300,000
+200,000
+200% +$19.2M 0.06% 454
2023
Q2
$9.18M Hold
100,000
0.02% 824
2023
Q1
$9.39M Buy
100,000
+54,400
+119% +$5.06M 0.02% 804
2022
Q4
$3.79M Hold
45,600
0.01% 1141
2022
Q3
$3.43M Buy
45,600
+32,600
+251% +$2.75M 0.01% 1213
2022
Q2
$1.14M Buy
+13,000
New +$1.35M ﹤0.01% 1693

Other funds holding LYB

Dmitry Balyasny's LYB Position: Q2 2026 in Review

Dmitry Balyasny increased its LyondellBasell Industries (LYB) stake by 118% in Q2 2026, buying an estimated $344K and bringing the position to 9,205 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #2526.

Dmitry Balyasny first reported a position in LYB in Q2 2014 and has held it in 31 quarters since. The position peaked at $110M in Q1 2023. 875 funds tracked by Wall St. Rank hold LYB as of Q2 2026.

  • Dmitry Balyasny held 9,205 shares of LyondellBasell Industries worth $485K as of Q2 2026.
  • Dmitry Balyasny bought 4,982 LyondellBasell Industries shares in Q2 2026, an estimated $344K.
  • LyondellBasell Industries made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2526 holding.
  • Dmitry Balyasny first reported a position in LyondellBasell Industries in Q2 2014 and has held it in 31 quarters since.
  • Dmitry Balyasny's LyondellBasell Industries position peaked at $110M in Q1 2023.
  • 875 funds tracked by Wall St. Rank held LyondellBasell Industries as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.